Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-κB activation induced by OX40 signaling

Biochemical and Biophysical Research Communications

Volumn 272, Issue 3, 2000, Pages 856-863

  Takaori Kondo, Akifumi ^a   Hori, Toshiyuki ^a   Fukunaga, Keiko ^a   Morita, Rinpei ^a   Kawamata, Shin ^a   Uchiyama, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

IKK ; NF B; NIK; OX40; TRAF2; TRAF3

Indexed keywords

ADAPTOR PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN INDUCING KINASE; MUTANT PROTEIN; PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 0034674314     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2860     Document Type: Article

References (39)

1. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. New Engl. J. Med. 334:1996;1717-1725.
2. Mallett S., Fossum S., Barclay A. N. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - A molecule related to nerve growth factor receptor. EMBO J. 9:1990;1063-1068.
3. Calderhead D. M., Buhlmann J. E., van den Eertwegh A. J., Claassen E., Noelle R. J., Fell H. P. Cloning of mouse Ox40: A T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:1993;5261-5271.
4. Latza U., Dürkop H., Schnittger S., Ringeling J., Eitelbach F., Hummel M., Fonatsch C., Stein H. The human OX40 homologue: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24:1994;677-683.
5. Baum P. R., Gayle R. B. III, Ramsdell F., Srinivasan S., Sorensen R. A., Watson M. L., Seldin M. F., Baker E., Sutherland G. R., Clifford K. N., Alderson M. R., Goodwin R. G., Fanslow W. C. Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13:1994;3992-4001.
6. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180:1994;757-762.
7. Imura A., Hori T., Imada K., Kawamata S., Tanaka Y., Imamura S., Uchiyama T. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: Implication for the possible involvement of OX40 in leukemic cell infiltration. Blood. 89:1997;2951-2958.
8. Matsumura Y., Imura A., Hori T., Uchiyama T., Imamura S. Localization of OX40/gp34 in inflammatory skin diseases: A clue to elucidate the interaction between activated T cells and endothelial cells in infiltration. Arch. Dermatol. Res. 289:1997;653-656.
9. Ohshima Y., Tanaka Y., Tozawz H., Takahashi Y., Maliszewski C., Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159:1997;3838-3848.
10. Jones D., Fletcher C. D. M., Pulford K., Shahsafaei A., Dorfman D. M. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. Blood. 93:1999;3487-3493.
11. Banner D. W., D'Arcy A., Janes W., Gentz R., Schoenfeld H. J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation. Cell. 73:1993;431-445.
12. Rothe M., Sarma V., Dixit V. M., Goeddel D. V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
13. Rothe M., Wong S. C., Henzel W. J., Goeddel D. V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
14. Hsu H., Xiong J., Goeddel D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
15. Hsu H, . Shu H.-B., Pan M.-G., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathway. Cell. 84:1996;299-308.
16. Malinin N. L., Boldin M. P., Kovalenko A. V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
17. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
18. Regnier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
19. Mercurio F., Zhu H., Murray B. W., Shevchenko A., Bennett B. L., Li J. W., Young D. B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866.
20. Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science. 278:1997;866-869.
21. Lee S. Y., Park C. G., Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183:1996;669-674.
22. Akiba H., Nakano H., Nishinaka S., Shindo M., Kobata T., Atsuta M., Morimoto C., Ware C. F., Malinin N. L., Wallach D., Yagita H., Okumura K. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-κB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-κB-inducing kinase. J. Biol. Chem. 273:1998;13353-13358.
23. Kawamata S., Hori T., Imura A., Takaori-Kondo A., Uchiyama T. Activation of OX40 signal transduction pathway leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273:1998;5808-5814.
24. Arch R. H., Thompson C. B. 4-1BB and OX40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell. Biol. 18:1998;558-565.
25. Park Y. C., Burkitt V., Villa A. R., Tong L., Wu H. Structure basis for self-association and receptor recognition of human TRAF2. Nature. 398:1999;533-538.
26. Nakano H., Oshima H., Chung W., Williams-Abbott L., Ware C. F., Yagita H., Okumura K. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:1996;14661-14664.
27. Ishida T., Mizushima S., Azuma S., Kobayashi N., Tojo T., Suzuki K., Aizawa S., Watanabe T., Nosialos G., Kieff E., Yamamoto T., Inoue J. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:1996;28745-28748.
28. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D. V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
29. Arch R. H., Gedrich R., Thompson C. B. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
30. Cheng G., Cleary A. M., Ye Z., Hong D. I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1995;1494-1498.
31. Xu Y., Cheng G., Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity. 5:1996;407-415.
32. VanArsdale T. L., VanArsdale S. L., Force W. R., Walker B. N., Mosialos G., Kieff E., Reed J. C., Ware C. F. Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci. USA. 94:1997;2460-2465.
33. Force W. R., Cheung T. C., Ware C. F. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272:1997;30835-30840.
34. Imura A., Hori T., Imada K., Ishikawa T., Tanaka Y., Maeda M., Imamura S., Uchiyama T. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183:1996;2185-2195.
35. Lin X., Mu Y., Cunnigham E. T. Jr., Marcu K. B., Geleziunas R., Greene W. C. Molecular determinants of NF-κB-inducing kinase action. Mol. Cell. Biol. 18:1998;5899-5907.
36. Geleziunas R., Ferrell S., Lin X., Mu Y., Cunningham E. T. Jr., Grant M., Connelly M. A., Hambor J. E., Marcu K. B., Greene W. C. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase a (IKKα) and IKKβ cellular kinases. Mol. Cell. Biol. 18:1998;5157-5165.
37. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J-I., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature. 398:1999;252-256.
38. Rothwarf D. M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1999;297-300.
39. Cohen L., Henzel W. J., Baeuerle P. A. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1999;292-296.